Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 USD | -4.35% | +4.76% | -12.18% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 17.18M | Capitalization | 174M |
---|---|---|---|---|---|
Net income 2024 * | -56M | Net income 2025 * | -59M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.2 x |
P/E ratio 2024 * |
-3.24
x | P/E ratio 2025 * |
-2.81
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.64% |
Latest transcript on Abeona Therapeutics Inc.
1 day | -4.35% | ||
1 week | +4.76% | ||
Current month | +6.28% | ||
1 month | -44.51% | ||
3 months | -37.23% | ||
6 months | +5.01% | ||
Current year | -12.18% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 21-05-31 |
Michael Amoroso
CHM | Chairman | 46 | 20-07-08 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 06-02-28 |
Faith Charles
BRD | Director/Board Member | 62 | 21-03-24 |
Leila Alland
BRD | Director/Board Member | 61 | 21-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 4.4 | -4.35% | 523,022 |
24-05-16 | 4.6 | -2.34% | 501,072 |
24-05-15 | 4.71 | +12.14% | 1,101,517 |
24-05-14 | 4.2 | -2.33% | 955,320 |
24-05-13 | 4.3 | +2.38% | 534,292 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.18% | 174M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- ABEO Stock